SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.87-0.2%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (10584)6/29/1999 8:38:00 PM
From: aknahow  Read Replies (1) of 17367
 
I think there is a lot to be said for T.A. Would have avoided buying so early if I had paid more attention.

BTW am on my second reading of the annual meeting presentation on the XOMA web site. Just a great presentation. However if you get into an automobile accident it apparently makes you sstutter if it is ssever enough.

Short example of one of the many things I found of interest.

<<<<<
Our LBP assay has three licensees: Biosite Diagnostics is in the clinic, DPC is
expected to enter the European market by the end of this year, and SRL is in
preclinical studies in Japan.>>>>>>>

<<<<<<<< DPC is
expected to enter the European market by the end of this year, >>>>>>>

We might have both news and royalties as a result of the DPC product this year. IMO. BTW all the Castello/XOMA remarks come with a standard non K but rather a S.E.C. approved disclaimer. So best visit the site to read it there. Am surprised there have been no comments yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext